Description
PULFIBRO 267 mg Capsule contains Pirfenidone, an anti-fibrotic and anti-inflammatory medication used in the treatment of Idiopathic Pulmonary Fibrosis (IPF) — a chronic, progressive lung disease that leads to scarring (fibrosis) of lung tissue. By reducing inflammation and slowing down fibrosis, PULFIBRO helps maintain lung function and improves the patient’s ability to breathe over time.
Pirfenidone works by modulating the activity of growth factors and cytokines involved in the fibrotic process, making it one of the few approved treatments for IPF.
 50ML.webp)
.webp)
 125ML.jpg)
 100ML.png)
 20ML.jpeg)
 200 ML.jpeg)
 200ML.webp)
 125ML.webp)
 200ML.jpg)
60 ML 60 ML.webp)
 40 ML.png)
 200ML.webp)
 15ML.webp)
 30 TAB.webp)
 250 ML.jpeg)
.webp)
 150GM.webp)
Change Language